Related Experiment Video
Updated: Nov 5, 2025

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
Sympathovagal imbalance decades after atrial septal defect repair: a long-term follow-up study
Mathias Alstrup1,2, Zarmiga Karunanithi1,2, Marie Ø Maagaard1,2
1Department of Cardiothoracic and Vascular Surgery, Aarhus University Hospital, Aarhus, Denmark.
Insights
Adults with corrected atrial septal defects (ASD) show impaired heart rate variability (HRV), indicating abnormal autonomic regulation. Surgical closure of ASDs resulted in more significant HRV reduction compared to percutaneous closure.
Area of Science:
- Cardiology
- Autonomic Nervous System Research
- Medical Device Technology
Background:
- Growing evidence links corrected atrial septal defects (ASD) to increased patient morbidity and mortality.
- Autonomic dysregulation of cardiac function is a potential contributing factor.
- Investigating heart rate variability (HRV) offers insights into autonomic control in these patients.
Purpose of the Study:
- To assess autonomic cardiac regulation in adults with corrected ASDs using HRV analysis.
- To compare HRV between surgically closed ASDs, percutaneously closed ASDs, and healthy controls.
Main Methods:
- A 48-hour Holter monitor was utilized to record heart rate.
- Heart rate variability (HRV) parameters were analyzed in adult patients with surgically or percutaneously closed ASDs.
- A control group of healthy individuals was included for comparison.
Main Results:
- Surgically closed ASD patients exhibited significantly reduced HRV across all six assessed parameters compared to controls.
- Percutaneously closed ASD patients demonstrated decreased HRV in three out of six parameters when compared to controls.
- The study included 17 surgically closed ASD, 18 percutaneously closed ASD, and 18 control participants.
Conclusions:
- Adults with ASDs, regardless of closure method (surgical or percutaneous), display impaired HRV.
- The reduction in HRV is more pronounced in individuals with surgically closed ASDs.
- These findings suggest a persistent impact on autonomic cardiac regulation following ASD correction.
Objectives:
Recent evidence suggests that patients with a corrected atrial septal defect (ASD) have higher morbidity and mortality. An abnormal autonomic regulation of the heart may be a part of the explanation for this. Our objective was to study heart rate variability (HRV) in adults with a corrected ASD as a prominent tool to investigate the autonomic regulation of the heart.
Methods:
Autonomic cardiac function was investigated in adults with either a surgically closed or percutaneously closed ASD and healthy control subjects. A 48-h Holter monitor was performed on each participant and HRV was assessed.
Results:
A total of 17 patients with surgically closed ASDs, 18 percutaneously closed ASDs and 18 controls were included. The mean age in the surgical group, percutaneous group and controls was 32 ± 9, 28 ± 7 and 32 ± 10 years, respectively. The mean time since closure was 19 ± 8 years for the surgical group and 15 ± 5 years for the percutaneous group. The surgically closed ASD patients showed decreased HRV in all six parameters studied when compared to the controls. Similarly, the percutaneously closed ASDs showed decreased HRV in three out of six parameters when compared to controls.
Conclusions:
Adults with an ASD, whether closed surgically or percutaneously, have impaired HRV compared to their age- and sex-matched controls, more so in the patients with a surgically closed ASD.
Clinical Trial Registration Number:
ClinicalTrials.gov (identifier: NCT03565471).
Related Concept Videos
Mitral Valve Prolapse II: Assessment and Management
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Mitral Stenosis I: Introduction
Mitral Regurgitation I: Introduction
Mitral Stenosis III: Medical Management
Mitral Regurgitation III: Medical Management

